Literature DB >> 9795865

Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides--a novel class of intraocular pressure lowering agents.

F Mincione1, L Menabuoni, F Briganti, G Mincione, A Scozzafava, C T Supuran.   

Abstract

A series of N-hydroxy sulfonamides has been prepared by reaction of alkyl-, arylalkyl- and arylsulfonyl halides or sulfonic acid anhydrides with hydroxylamine. Structurally related inhibitors were also obtained from acyl chlorides and hydroxylamine, as well as by reaction of tosyl isocyanate with hydroxylamine, sulfamic acid and sulfamide. Inhibition of three carbonic anhydrase (CA) isozymes, hCA I, hCA II and bCA IV (h = human; b = bovine) with the prepared compounds has been investigated. Good inhibitors, as well as compounds with moderate activity against these isozymes were detected, depending on the R group to which the SO2NHOH or CONHOH moieties were attached. Susceptibility to inhibition was generally: hCA II > bCA IV >> hCA I. Some of the new inhibitors showed very good antiglaucoma action when administered directly into the eye in experimental animals, acting as more efficient intraocular pressure lowering agents as compared to the clinical drug dorzolamide. This constitutes an encouraging result for obtaining novel antiglaucoma drugs from this class of CA inhibitors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795865     DOI: 10.3109/14756369809021475

Source DB:  PubMed          Journal:  J Enzyme Inhib        ISSN: 1026-5457


  5 in total

Review 1.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

Review 2.  Clinical pharmacokinetics of dorzolamide.

Authors:  Jens Martens-Lobenhoffer; Peter Banditt
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

4.  Synthetic methodology for the preparation of N-hydroxysulfamides.

Authors:  Krishnaswamy Devanathan; Jennifer A Bell; Patricia C Wilkins; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2007-11-05       Impact factor: 2.415

5.  Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II.

Authors:  Nurgün Büyükkıdan; Bülent Büyükkıdan; Metin Bülbül; Rahmi Kasımoğulları; Samet Mert
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.